Altimmune COVID-19 Response

Click here to read about AdCOVIDTM Intranasal COVID-19 Vaccine and T-COVIDTM Intranasal Therapeutic for COVID-19 infection

Click here if you are interested in enrolling in our T-COVID EPIC Clinical Study

OUR PROGRAMS

liver icon
Peptide-Based Therapeutics for Liver Diseases
Peptide-Conjugated Immunostimulants for Cancer - Icon
Peptide-Conjugated Immunostimulants for Cancer
Intranasal vaccines for Anthrax and Influenza - icon
Intranasal Vaccines & Therapeutics for Anthrax, Influenza and COVID-19

OUR PIPELINE

Our diverse pipeline includes treatments for NASH (ALT-801), chronic Hepatitis B (HepTcell™), and conjugated immunostimulants for the treatment of cancer (ALT-702). In addition, we are developing intranasal vaccine & therapeutic candidates for anthrax, influenza and COVID-19.

LIVER THERAPIES

liver therapies iconALT-801
liver therapies iconHepTcell™

CANCER

cancer iconALT-702

INTRANASAL VACCINES & THERAPEUTICS

intranasal vaccines iconNasoVAX™
intranasal vaccines iconNasoShield™
intranasal vaccines iconAdCOVID™
intranasal vaccines iconT-COVID™
VIEW PIPELINE